GP-Act III Acquisition Corp.GPAT
Cash in trust
$303M
$302,970,091
Trust per share
$10.54
Redemption value
IPO
May 2024
$288M raised
Combination deadline
Nov 13, 2026
26 days remaining
Filings on record
81
Latest Oct 17, 2026
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- May 14, 2026
Overview
GP-Act III Acquisition Corp. is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001834526. It completed its initial public offering in May 2024, raising $288M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker GPAT, units under GPATU, warrants under GPATW on Nasdaq. The vehicle is sponsored by GP-Act. The mandate targets generalist. Definitive business-combination agreement signed, closing pending.
“we intend to focus our search on high potential businesses based in the United States.”
Reading the filings
Arithmetic on what GP-Act III Acquisition Corp. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trading at a premium to trust
At $11.08 the shares trade 5.14% above the $10.54 redemption floor. Above trust the market is paying for the announced or expected deal rather than for the cash, so the premium is what is at risk if the combination does not close.
Trust versus the $10 unit
The trust holds $10.54 per public share, 5.4% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Time on the clock
26 days to the Nov 13, 2026 deadline. Inside ninety days a sponsor has three routes and no others: close, call a shareholder vote to extend (which opens a redemption window and usually costs a monthly contribution into the trust), or liquidate and return the cash. This is the window where redemption arithmetic starts to dominate the share price.
Extension history
Shareholders have already approved 3 extensions. Each one opened a redemption window, so the public float and the trust are almost certainly smaller than at IPO, and each typically came with a sponsor contribution that lifts trust per share. A vehicle on its second or third extension is one where the sponsor is paying to keep the search alive.
Sponsor promote
The sponsor's founder block is 3,220,000 shares against 28,750,000 public shares, or 10.1% of the combined count, acquired before the IPO at nominal cost. That promote is the structural dilution every public shareholder carries into a combination, and it is why the economics of a de-SPAC differ so sharply from a conventional IPO.
Warrant coverage
Each unit carried one-half of one warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.
Underwriting
Cantor Fitzgerald led the offering. It has been named on 151 SPAC IPOs, book-running 130 of them, and 69.5% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
From listing to the date GP-Act III Acquisition Corp. must close a deal, extend again, or return the trust. The marker is today.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
81 filings in all. 4 in the last three months, against a busiest month of 17.
Scores
Recomputed 1d agoThree readings of GP-Act III Acquisition Corp., each an unweighted mean of the components shown beneath it, and each component a percentile against every live SPAC rather than an absolute we invented. They describe the setup, not the merit. How they are built
Edge
ModerateHow much does the structure protect a holder right now?
34/100
- Discount to trust4
-5.14%
- Trust accretion75
$10.54 per share
- Runway22
28 days
Edge reads the setup, not the business. A vehicle can score well on protection and still be a poor place to leave money once a deal closes.
FOMO
ModerateHow much attention is this vehicle attracting right now?
45/100
- Filing activity17
1 in 30 days
- News coverage0
0 stories in 30 days
- Premium to trust96
5.14%
- Deal freshness65
announced 156 days ago
Attention is not quality. FOMO rises on news volume and on the market paying above trust, both of which have preceded plenty of disappointments.
Potential
HighHow likely is this vehicle to complete a combination, and at what scale?
82/100
- Lead bank record67
52.5%
- Bank franchise85
114 SPAC mandates
- Trust scale90
$303M
- Stage85
definitive agreement signed
Potential is about execution, not about the target. It says nothing about whether the eventual deal is worth owning, because the target is usually unknown when the score is computed.
These are derived measures, not ratings of investment merit. They carry no view on the target, no price target and no recommendation, and a high score is not a reason to buy anything.
News on GP-Act III Acquisition Corp.
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- PRE 14A
PRELIMINARY PROXY STATEMENT
Accession 0001213900-26-110307
- 10-Q
Quarterly report
Accession 0001213900-26-090162
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001604488-26-000091
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001167557-26-000222
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001072613-26-000507
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001326389-26-000040
- 10-Q
Quarterly report
Accession 0001213900-26-056642
- 425
Business-combination communication
Accession 0001213900-26-056070
- 8-K
Entry into a material definitive agreement; Submission of matters to a vote of security holders
Items 1.01, 5.03, 5.07, 9.01 · Accession 0001213900-26-056065
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001213900-26-055248
- 8-K
Other events
Item 8.01 · Accession 0001213900-26-053043
- DEFA14A
Additional proxy soliciting material
Accession 0001213900-26-052797
- 8-K
Submission of matters to a vote of security holders
Item 5.07 · Accession 0001213900-26-052786
- 8-K
Other events
Item 8.01 · Accession 0001213900-26-051802
- DEFA14A
Additional proxy soliciting material
Accession 0001213900-26-049269
- 8-K
Submission of matters to a vote of security holders
Item 5.07 · Accession 0001213900-26-049265
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001539041-26-000009
- DEF 14A
Definitive proxy statement
Accession 0001213900-26-036417
- 10-K
Annual report
Accession 0001213900-26-034846
- PRE 14A
PROXY STATEMENT
Accession 0001213900-26-031944
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000927971-26-000013
- 10-Q
Quarterly report
Accession 0001213900-25-109975
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000927971-25-000035
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001072613-25-000600
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001326389-25-000266
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001905106-25-000026
- 10-Q
Quarterly report
Accession 0001213900-25-075661
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001062993-25-014214
- 10-Q
Quarterly report
Accession 0001213900-25-043106
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001062993-25-009259
Pro
Track GPAT without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
GP-Act III Acquisition Corp.: questions answered
What is GP-Act III Acquisition Corp. (GPAT)?
GP-Act III Acquisition Corp. is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001834526. It completed its initial public offering in May 2024, raising $288M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker GPAT, units under GPATU, warrants under GPATW on Nasdaq. The vehicle is sponsored by GP-Act. The mandate targets generalist. Definitive business-combination agreement signed, closing pending.
How much does GP-Act III Acquisition Corp. hold in trust?
Approximately $302,970,091, or about $10.54 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must GP-Act III Acquisition Corp. complete a merger?
By Nov 13, 2026, after 3 shareholder-approved extensions. If no combination closes by then the sponsor must seek a further extension or wind the vehicle up and return the trust.
What happens if GP-Act III Acquisition Corp. does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in GP-Act III Acquisition Corp., and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.54 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
What tickers does GP-Act III Acquisition Corp. trade under?
Class A shares trade as GPAT on Nasdaq, the units as GPATU, and the warrants as GPATW. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.
Is the trust value the same as the share price for GP-Act III Acquisition Corp.?
No, and the gap between them is the whole trade. Trust per share is a disclosed, contractual figure of $10.54, being what a redeeming holder receives. The market price is whatever the shares change hands at: most recently $11.08, a premium of 5.14% to the redemption value. Quotes on this site are delayed and indicative; confirm on your own venue before trading.
How much dilution do GP-Act III Acquisition Corp.'s founder shares and warrants create?
The founder block is 3,220,000 shares against 28,750,000 public shares, so roughly 10.1% of the combined count sits with the sponsor at nominal cost. Each unit also carried one-half of one warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.
Who sponsors GP-Act III Acquisition Corp., and what is their track record?
GP-Act is the sponsor entity, part of the GP-Act franchise. This is the only vehicle we have attributed to that sponsor. Named principals: Antonio Bonchristiano.
Which banks underwrote the GP-Act III Acquisition Corp. IPO?
Cantor Fitzgerald. Cantor Fitzgerald was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is GP-Act III Acquisition Corp. tradeable, and where?
Yes. GPAT returned a live quote of $11.08 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.
Is GP-Act III Acquisition Corp. a good investment?
That is not a question this site answers. GP-Act III Acquisition Corp. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this GP-Act III Acquisition Corp. data come from?
Filings GP-Act III Acquisition Corp. submitted to the SEC under CIK 0001834526: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 18, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
GP-Act: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Cantor Fitzgerald in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Generalist SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All spacs with an announced deal
Definitive business-combination agreement signed, closing pending.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.